CN1322890C - Medicine for treating gastric ulcer - Google Patents
Medicine for treating gastric ulcer Download PDFInfo
- Publication number
- CN1322890C CN1322890C CNB200410023064XA CN200410023064A CN1322890C CN 1322890 C CN1322890 C CN 1322890C CN B200410023064X A CNB200410023064X A CN B200410023064XA CN 200410023064 A CN200410023064 A CN 200410023064A CN 1322890 C CN1322890 C CN 1322890C
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- rhizoma
- roots
- bletillae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses a specific medicine for curing gastric ulcers, which uses bupleurum roots, rhizoma corydalis, tribulus terrestris, lignum dalbergiae odoriferae, rhubarb, calamus, lemonfragrant ostericum roots, sedge, pungent litse fruit, taiwan beautyberry leaves, bunge auriculate roots, capparis versicolor griff, rhizoma bletillae, futokadsura stem, stephania sinica and baiyangchun as raw materials. After processing, the raw materials are prepared into honey pills proportionally. The medicine uses the pick of the basket of patrimonial secret folk recipes and proved recipes, and is refined through repeated practice researches, careful filtration and scientific formulation according to the therapy of dozens of thousands cases for more than 50 years. The medicine is a traditional Chinese medicine having good curative effect, obvious effect, strong hemostasis performance, no toxic effect and no side effect, and has the functions of regulating qi to make qi go downward, relieving inflammation, alleviating pain, activating the blood circulation, stopping bleeding, removing blood stasis for promoting tissue regeneration, reinforcing spleens and reinforcing stomachs. The medicine is mainly used for curing stomach ulcers, duodenal ulcers, gastric hemorrhage, and various kinds of chronic gastritis and superficial gastritis.
Description
Technical field
The present invention relates to a kind of specific medicament for the treatment of gastric ulcer, specifically is a kind of Chinese herbal medicine pill, cures mainly stomach, duodenal ulcer, gastrorrhagia and various chronic, superficial gastritis.
Technical background
Gastropathy sickness rate height, hazardness is big, seriously influence the healthy of people, and the conventional medicine of treatment has SANJIU WEITAI at present, medicine such as bismuth potassium citrate, ranitidine, and these medicines can only play mitigation, produce little effect, and severe patient has to adopt the surgical resection therapy method, brings great misery and to the health lasting influence to the patient.In the Therapeutic Method of inquiring into gastropathy, breakthrough is not arranged as yet, generally acknowledged ideal medicament is not arranged so far.
Summary of the invention
The present invention just provides a kind of specific medicament for the treatment of gastric ulcer, mainly is treatment stomach, duodenal ulcer, gastrorrhagia and various chronic, superficial gastritis.This drug utilization passes on from one to another for generations, the elite of folk secret, proved recipe, and by the treatment of five more than ten years and tens thousand of surplus examples, through repeatedly practising research, screening meticulously, scientific formula is refining to form.Be that a kind of curative effect is reliable, instant effect, hemostasis power is strong, has no side effect, and has the traditional Chinese medical science medicine of descending, the anti-inflammatory analgetic of regulating the flow of vital energy, promoting blood circulation and hemostasis, promoting tissue regeneration by removing blood stasis, spleen reinforcing stomach reinforcing.
Medicine of the present invention is made by following component: Radix Bupleuri 20-30, Rhizoma Corydalis 10-15, Fructus Atriplicis Sibiricae 20-30, Lignum Dalbergiae Odoriferae 20-30, Radix Et Rhizoma Rhei 5-8, water Rhizoma Acori Graminei 10-15, Radix osterici citriodori (Radix Angelicae Citriodorae) 10-15, dried tuber 10-15, MUZHANGZI 20-30, Folium Callicarpae Formosanae 10-15, swollen three types of diabetes 10-15, a Semen Capparis 10-15, Pseudobulbus Bletillae (Rhizoma Bletillae) 20-30, Caulis Piperis Kadsurae 10-15, Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) 10-15, BAIYANGCHUN 10-15.
Optimum weight (part) proportioning of preparation medicine of the present invention is: Radix Bupleuri 30, Rhizoma Corydalis 10, Fructus Atriplicis Sibiricae 30, Lignum Dalbergiae Odoriferae 30, Radix Et Rhizoma Rhei 5, water Rhizoma Acori Graminei 10, Radix osterici citriodori (Radix Angelicae Citriodorae) 10, dried tuber 10, MUZHANGZI 30, Folium Callicarpae Formosanae 10, one swollen three types of diabetes 10, Semen Capparis 10, Pseudobulbus Bletillae (Rhizoma Bletillae) 30, Caulis Piperis Kadsurae 10, Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) 10, BAIYANGCHUN 10.
Said medicine is in the clinical treatment to the patients with gastric disease of example surplus 30,000, no matter the patient age size, course of disease length, size are repeatedly hemorrhage, only need take 1-3 the course of treatment, can cure.And effective percentage reaches more than 98%, and cure rate is up to more than 95%, and the haemostatic effect of this medicine is quite efficacious especially, and not angiorrbagia size was all stopped at 1-3 days, and no longer recurrence.
For showing the therapeutic effect of medicine of the present invention to gastropathy, the present invention is through the clinical observation of 100 routine systems, and to select 30 routine patients with gastric disease be matched group.Treatment group 100 example medicine of the present invention, matched group 30 is routine uses conventional therapy, the medication 3-180 days observation survey state of an illness, reuse other drug not during this period.Curative effect determinate standard is: recovery from illness: stomach recovers normal; Produce effects: rehabilitation is more than 65%; Progressive: between the rehabilitation 30-50%; Invalid: state of an illness no change.Clinical test results such as subordinate list
Rank | The example number | Recovery from illness | Produce effects | Progressive | Invalid |
The treatment group | 100 | ?95(95.0) | 3(3.0) | 2(2.0) | 0 |
Matched group | 30 | ?9(30.0) | 12(40.0) | 6(20.0) | 3(10.0) |
But pain, anti-inflammation hemostasia in the Radix Et Rhizoma Rhei in this medicine composition, a swollen three types of diabetes, Rhizoma Corydalis, Semen Capparis, Folium Callicarpae Formosanae, Radix osterici citriodori (Radix Angelicae Citriodorae), dried tuber, Caulis Piperis Kadsurae, Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae), the BAIYANGCHUN circulation of qi promoting; Radix Bupleuri, Lignum Dalbergiae Odoriferae, water Rhizoma Acori Graminei, MUZHANGZI, Fructus Atriplicis Sibiricae, Pseudobulbus Bletillae (Rhizoma Bletillae), BAIYANGCHUN then are the effect of depressed liver-energy dispersing and QI regulating, the block up granulation promoting of dispelling, spleen reinforcing stomach reinforcing.In visual report, 90% patient takes the pain disappearance in 3 days of this medicine or alleviates, and takes and just recovers normal in 7-13 days, takes medicine the drug withdrawal of just can fully recovering again 7 days.Find out that from above table treatment group cure rate of the present invention always effectively up to 98%, is not found untoward reaction more than 95% in whole therapeutic process.
The specific embodiment
Describe embodiments of the invention below in detail:
1. prescription composition: Radix Bupleuri 30, Rhizoma Corydalis 10, Fructus Atriplicis Sibiricae 30, Lignum Dalbergiae Odoriferae 30, Radix Et Rhizoma Rhei 5, water Rhizoma Acori Graminei 10, Radix osterici citriodori (Radix Angelicae Citriodorae) 10, dried tuber 10, MUZHANGZI 30, Folium Callicarpae Formosanae 10, one swollen three types of diabetes 10, Semen Capparis 10, Pseudobulbus Bletillae (Rhizoma Bletillae) 30, Caulis Piperis Kadsurae 10, Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) 10, BAIYANGCHUN 10.
2. embodiment
(1) takes by weighing raw material by following proportioning: (gram)
Radix Bupleuri 30g, Rhizoma Corydalis 10g, Fructus Atriplicis Sibiricae 30g, Lignum Dalbergiae Odoriferae 30g, Radix Et Rhizoma Rhei 5g, water Rhizoma Acori Graminei 10g, Radix osterici citriodori (Radix Angelicae Citriodorae) 10g, dried tuber 10g, MUZHANGZI 30g, Folium Callicarpae Formosanae 10g, swollen three types of diabetes 10g, a Semen Capparis 10g, Pseudobulbus Bletillae (Rhizoma Bletillae) 30g Caulis Piperis Kadsurae 10g, Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) 10g, BAIYANGCHUN 10g.
(2) get Fructus Atriplicis Sibiricae 30g, Lignum Dalbergiae Odoriferae 30g, Pseudobulbus Bletillae (Rhizoma Bletillae) 30g, Tetranthera citrata 30g, Radix Bupleuri 30g with 1: 3 water logging bubble 24 hours, reuse slow fire decocts, and endures to the liquid medicine ratio to reach 1: 1, the filter and remove residue taking liquid.
(3) medicinal liquid that makes was soaked the other medicines that take by weighing in ratio in (1) 36 hours, treat that medicine fully absorbs medicinal liquid after, again medicine is dried.
(4) will dry medicine and grind into powder, and make 100 order fine powders and add Mel and mix thoroughly and do ball.
Instructions of taking: at every turn take the 2-4 ball, every day 3-4 time.This be one the course of treatment consumption.
Claims (2)
1. medicine for the treatment of gastric ulcer, it is characterized in that: it is made by the following weight proportion raw material: Radix Bupleuri 20-30, Rhizoma Corydalis 10-15, Fructus Atriplicis Sibiricae 20-30, Lignum Dalbergiae Odoriferae 20-30, Radix Et Rhizoma Rhei 5-8, water Rhizoma Acori Graminei 10-15, Radix osterici citriodori (Radix Angelicae Citriodorae) 10-15, dried tuber 10-15, MUZHANGZI 20-30, Folium Callicarpae Formosanae 10-15, swollen three types of diabetes 10-15, a Semen Capparis 10-15, Pseudobulbus Bletillae (Rhizoma Bletillae) 20-30, Caulis Piperis Kadsurae 10-15, Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) 10-15, BAIYANGCHUN 10-15.
2. a kind of medicine for the treatment of gastric ulcer according to claim 1, it is characterized in that: it is made by the following weight proportion raw material: Radix Bupleuri 30, Rhizoma Corydalis 10, Fructus Atriplicis Sibiricae 30, Lignum Dalbergiae Odoriferae 30, Radix Et Rhizoma Rhei 5, water Rhizoma Acori Graminei 10, Radix osterici citriodori (Radix Angelicae Citriodorae) 10, dried tuber 10, MUZHANGZI 30, Folium Callicarpae Formosanae 10, one swollen three types of diabetes 10, Semen Capparis 10, Pseudobulbus Bletillae (Rhizoma Bletillae) 30, Caulis Piperis Kadsurae 10, Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) 10, BAIYANGCHUN 10.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200410023064XA CN1322890C (en) | 2004-03-29 | 2004-03-29 | Medicine for treating gastric ulcer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200410023064XA CN1322890C (en) | 2004-03-29 | 2004-03-29 | Medicine for treating gastric ulcer |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1676146A CN1676146A (en) | 2005-10-05 |
CN1322890C true CN1322890C (en) | 2007-06-27 |
Family
ID=35048997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200410023064XA Expired - Fee Related CN1322890C (en) | 2004-03-29 | 2004-03-29 | Medicine for treating gastric ulcer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1322890C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103041046A (en) * | 2013-01-25 | 2013-04-17 | 怀化医学高等专科学校 | Application of callicarpa kwangtungensis and extract thereof in preparation of anti-peptic ulcer medicaments |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102284008B (en) * | 2011-07-21 | 2012-08-29 | 刘湘秋 | Chinese medicinal granules for treating gastric ulcer and duodenal ulcer |
CN105030904A (en) * | 2015-06-08 | 2015-11-11 | 洪国隆 | Medical and edible dual-purpose Chinese herbal medicine composition for treating intestinal tract disease as well as preparation method and application of medical and edible dual-purpose Chinese herbal medicine composition |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1362257A (en) * | 2001-12-26 | 2002-08-07 | 邹明义 | Gastrosis treating Chinese medicine prepn. |
-
2004
- 2004-03-29 CN CNB200410023064XA patent/CN1322890C/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1362257A (en) * | 2001-12-26 | 2002-08-07 | 邹明义 | Gastrosis treating Chinese medicine prepn. |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103041046A (en) * | 2013-01-25 | 2013-04-17 | 怀化医学高等专科学校 | Application of callicarpa kwangtungensis and extract thereof in preparation of anti-peptic ulcer medicaments |
Also Published As
Publication number | Publication date |
---|---|
CN1676146A (en) | 2005-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103386022A (en) | Chinese medicine composition for treating tuberculous pleurisy | |
CN101129578A (en) | Frankincense bedsore powder | |
CN101837096B (en) | Enema medicament for curing ulcerative colitis | |
CN102283896B (en) | Drug for curing chronic allergic rhinitis | |
CN1322890C (en) | Medicine for treating gastric ulcer | |
CN101411762A (en) | Chinese medicinal composition for treating Canine parvovirus disease and preparation thereof | |
CN100411666C (en) | Broad-specturm medicine for treating snake venom poisoning | |
CN103054952A (en) | Medicine for treating periodontitis and preparation method thereof | |
CN102836275A (en) | Medicine for treating hypertension | |
CN1167455C (en) | Medicine for treating acne and its preparing process | |
CN101822811B (en) | Medicine treating pancreatitis | |
CN1270754C (en) | Gastropathy treating medicine and its preparation | |
CN1277571C (en) | Chinese medicine preparation for stomach diseases | |
CN104998019B (en) | A kind of promoting blood circulation and removing blood stasis, Chinese medicine composition of hemostasis and pain-relieving | |
CN105012642B (en) | A kind of promoting blood circulation and removing blood stasis, preparation method of the Chinese medicine composition of hemostasis and pain-relieving | |
CN106943485B (en) | Traditional Chinese medicine compound preparation for treating anemia caused by blood heat bleeding and preparation method | |
CN1282610A (en) | Medicine for treating gastrointestinal tract diseases and preparation method thereof | |
CN106668787A (en) | Traditional Chinese medicine honeyed pill for treating hepatonecrosis and liver cancer and preparation method of traditional Chinese medicine honeyed pill | |
CN101433662A (en) | Prescription containing double formulas for quickly treating scrofula and processing | |
CN101953943A (en) | Traditional Chinese medicine for treating chronic aplastic anemia | |
CN106581269A (en) | Skin allergy treating traditional Chinese medicine composition | |
CN1899558A (en) | Medicine composition for treating stomach diseases and preparation method and application thereof | |
CN1772221A (en) | Mastosis treating Chinese medicine | |
CN105770034A (en) | Chinese herbal preparation for treating femoral head necrosis and preparing method and application thereof | |
CN1167437C (en) | Prescription of medicine for curing heloma and planter wart |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |